Entries for September 2021
Announcements
23Strands is pleased to be announcing its strategic IVF research partnership and our success with securing a $3 million federal government MRFF grant, for a world-first AI IVF study with our research partners Monash University and Virtus Health.
Fertility23
In recent research, the technical capability of wholly Australian-owned bioinformatics start-up, 23Strands, to decipher big data about genomics is revolutionising scientific research in women’s health. 23Strands’ work in genomics was linked with known molecular pathways for endometriosis to identify key genes associated with the disease.
Announcements
Med-tech start-ups accelerated towards commercial success
Cardio23
The future of cardiovascular disease management lies in technology, the COVID-19 pandemic has been a case study for the success and uptake of digital health technology.
Research News
Genetic sequencing is becoming the catalyst for a new area of patients no longer interested in a “cookie cutter” diagnosis.
Cancer23
Both sexes have the same risk for inherited gene mutations, such as BRCA1/2 and PALB2.
Cardio23
Improved lifestyle choices can influence heart disease risk and slow down the progression of heart disease
Cancer23
The potential of mRNA technology goes well beyond COVID into some of our most prevalent diseases, from the flu to heart disease and even cancer.